CVCT 2018

Washington D.C. | November 29 - December 1, 2018

Scroll down


CVCT is a true forum where scientific productivity and peer-to-peer exchange are at their best.


The meeting encourages knowledge-sharing between participants as CVCT aims to familiarize practitioners and investigators with the science of clinical trials from protocol design to result interpretation. Further, CVCT Forum puts attendees into direct contact with primary investigators, senior trial scientists as well as research and development experts from pharmaceutical/device companies and experts from regulatory agencies.


A unique mix

CVCT 2018 - A unique Mix

The CVCT meetings are unique, bringing together a carefully selected faculty of Key Opinion Leaders (KOL), clinical trialists, investigators, regulators, statisticians, industry R&D experts, decision makers and practitioners. Over the years CVCT has attracted an audience from over 30 different countries, with participants coming from Western and Eastern Europe, the USA, Canada, South America, Asia and The Middle East.

This was truly one of the most interesting meetings I’ve ever attended, and I’ve blocked my calendar for next year.
— Ellis Unger, Acting Director, Office of New Drugs - Office of Dru g Evaluation I (ODE I), FDA, USA
It was a stimulating and interesting meeting.
— Robert Califf, Former Commissioner, Office of Medical Products and Tobacco, FDA, USA
Thank you for the amazing meeting and the great collaboration. This was an incredibly successful meeting with so much to
learn from!
— Roxana Mehran, Professor of Medicine and Director of Interventional Cardiovascular Research and Clinical Trials, Mount Sinai School of Medicine; Chief Scientific Officer, Clinical Trials Center, Cardiovascular Research Foundation, USA
It was really successful. I enjoyed particularly the discussions about differences between regulatory agencies, and regional differences in trials.
— Kaori Shinagawa, Senior Scientist for Clinical Medicine, Pharmaceuticals and Medical Devises Agency, Japan